Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pathogens & immunity

Showing results (101-110 of 210) with videos related to

Pageof 21
Sort By:
Pathogens & Immunity|May 22, 2024
Invasive and Non-invasive Clinical <i>Haemophilus influenzae</i> Type A Isolates Activate Differentiated HL-60 Cells <i>In Vitro</i>Courtney L Ferris, Marina Ulanova
Pathogens & Immunity|May 1, 2024
Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer TherapyIrem Karaman, Asmita Pathak, Defne Bayik, et al.
Pathogens & Immunity|January 15, 2024
Normospermic Patients Infected With <i>Ureaplasma parvum:</i> Role of Dysregulated miR-122-5p, miR-34c-5, and miR-141-3pMarilena Galdiero, Carolo Trotta, Maria Teresa Schettino, et al.
Pathogens & Immunity|May 14, 2021
Plasma Extracellular Vesicle Subtypes May be Useful as Potential Biomarkers of Immune Activation in People With HIVWilfried Wenceslas Bazié, Julien Boucher, Julien Vitry, et al.
Pathogens & Immunity|September 8, 2022
Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of <i>Vibrio cholerae</i> O1 VaccinationOwen Jensen, Shubhanshi Trivedi, Kelin Li, et al.
Pathogens & Immunity|September 8, 2022
An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and InfluenzaEmmanuel Y Merigeon, Dong Yang, Elizabeth A Ihms, et al.
Pathogens & Immunity|September 23, 2022
Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of <i>Vibrio cholerae</i> O1 VaccinationOwen Jensen, Shubhanshi Trivedi, Jackson G Cacioppo, et al.
Pathogens & Immunity|January 6, 2022
Soluble Tumor Necrosis Factor Receptor 1 is Associated With Cardiovascular Risk in Persons With Coronary Artery Calcium Score of ZeroTony Dong, Graham Bevan, David A Zidar, et al.
Pathogens & Immunity|March 23, 2022
Planes, Trains, and Automobiles: Use of Carbon Dioxide Monitoring to Assess Ventilation During TravelJennifer L Cadnum, Heba Alhmidi, Curtis J Donskey
Pathogens & Immunity|June 6, 2017
Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV InfectionRobert M Paris, Lucimar G Milagres, Eirini Moysi, et al.
Pageof 21

Showing results (101-110 of 210) with videos related to

Sort By:
Pageof 21
Pathogens & Immunity|May 22, 2024
Invasive and Non-invasive Clinical <i>Haemophilus influenzae</i> Type A Isolates Activate Differentiated HL-60 Cells <i>In Vitro</i>Courtney L Ferris, Marina Ulanova
Pathogens & Immunity|May 1, 2024
Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer TherapyIrem Karaman, Asmita Pathak, Defne Bayik, et al.
Pathogens & Immunity|January 15, 2024
Normospermic Patients Infected With <i>Ureaplasma parvum:</i> Role of Dysregulated miR-122-5p, miR-34c-5, and miR-141-3pMarilena Galdiero, Carolo Trotta, Maria Teresa Schettino, et al.
Pathogens & Immunity|May 14, 2021
Plasma Extracellular Vesicle Subtypes May be Useful as Potential Biomarkers of Immune Activation in People With HIVWilfried Wenceslas Bazié, Julien Boucher, Julien Vitry, et al.
Pathogens & Immunity|September 8, 2022
Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of <i>Vibrio cholerae</i> O1 VaccinationOwen Jensen, Shubhanshi Trivedi, Kelin Li, et al.
Pathogens & Immunity|September 8, 2022
An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and InfluenzaEmmanuel Y Merigeon, Dong Yang, Elizabeth A Ihms, et al.
Pathogens & Immunity|September 23, 2022
Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of <i>Vibrio cholerae</i> O1 VaccinationOwen Jensen, Shubhanshi Trivedi, Jackson G Cacioppo, et al.
Pathogens & Immunity|January 6, 2022
Soluble Tumor Necrosis Factor Receptor 1 is Associated With Cardiovascular Risk in Persons With Coronary Artery Calcium Score of ZeroTony Dong, Graham Bevan, David A Zidar, et al.
Pathogens & Immunity|March 23, 2022
Planes, Trains, and Automobiles: Use of Carbon Dioxide Monitoring to Assess Ventilation During TravelJennifer L Cadnum, Heba Alhmidi, Curtis J Donskey
Pathogens & Immunity|June 6, 2017
Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV InfectionRobert M Paris, Lucimar G Milagres, Eirini Moysi, et al.
Pageof 21